Scinai Immunotherapeutics Ltd. (SCNI)
NASDAQ: SCNI · Real-Time Price · USD
4.530
+1.130 (33.24%)
At close: Sep 18, 2024, 4:00 PM
4.460
-0.070 (-1.55%)
After-hours: Sep 18, 2024, 7:59 PM EDT

Scinai Immunotherapeutics Statistics

Total Valuation

SCNI has a market cap or net worth of $3.80 million. The enterprise value is $21.55 million.

Market Cap 3.80M
Enterprise Value 21.55M

Important Dates

The next estimated earnings date is Tuesday, October 29, 2024, before market open.

Earnings Date Oct 29, 2024
Ex-Dividend Date n/a

Share Statistics

SCNI has 838,578 shares outstanding. The number of shares has increased by 96.30% in one year.

Shares Outstanding 838,578
Shares Change (YoY) +96.30%
Shares Change (QoQ) +25.87%
Owned by Insiders (%) 7.76%
Owned by Institutions (%) 2.36%
Float 730,725

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 8.16
Forward PS n/a
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 75.87
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.19

Current Ratio 2.19
Quick Ratio 1.91
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -28.35%
Return on Capital (ROIC) -31.73%
Revenue Per Employee $9,161
Profits Per Employee -$119,484
Employee Count 31
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -53.78% in the last 52 weeks. The beta is 2.48, so SCNI's price volatility has been higher than the market average.

Beta (5Y) 2.48
52-Week Price Change -53.78%
50-Day Moving Average 3.95
200-Day Moving Average 4.66
Relative Strength Index (RSI) 64.80
Average Volume (20 Days) 34,640

Short Selling Information

Short Interest 10,066
Short Previous Month 6,212
Short % of Shares Out 1.20%
Short % of Float 1.38%
Short Ratio (days to cover) 0.36

Income Statement

In the last 12 months, SCNI had revenue of $284,000 and -$3.70 million in losses. Loss per share was -$7.24.

Revenue 284,000
Gross Profit -164,000
Operating Income -7.88M
Pretax Income -19.70M
Net Income -3.70M
EBITDA -7.00M
EBIT -7.88M
Loss Per Share -$7.24
Full Income Statement

Balance Sheet

The company has $3.08 million in cash and $20.82 million in debt, giving a net cash position of -$17.75 million or -$21.16 per share.

Cash & Cash Equivalents 3.08M
Total Debt 20.82M
Net Cash -17.75M
Net Cash Per Share -$21.16
Equity (Book Value) -7.28M
Book Value Per Share -8.70
Working Capital 1.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.67 million and capital expenditures -$262,000, giving a free cash flow of -$6.93 million.

Operating Cash Flow -6.67M
Capital Expenditures -262,000
Free Cash Flow -6.93M
FCF Per Share -$8.26
Full Cash Flow Statement

Margins

Gross Margin -57.75%
Operating Margin -2,774.65%
Pretax Margin -1,304.23%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SCNI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -96.30%
Shareholder Yield -96.30%
Earnings Yield -97.51%
FCF Yield -182.43%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on May 21, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date May 21, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

SCNI has an Altman Z-Score of -13.45 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -13.45
Piotroski F-Score 1